Moderna (NASDAQ: MRNA) has helped many investors get rich over the past year. The coronavirus vaccine made Moderna profitable after only one full quarter of sales -- and profit topped $1 billion. The coronavirus vaccine giant predicts $20 billion in vaccine sales this year.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting